Psilocybin
Psilocybin is a pharmaceutical drug with 175 clinical trials. Currently 80 active trials ongoing. Historical success rate of 93.8%.
Success Metrics
Based on 60 completed trials
Phase Distribution
Phase Distribution
77
Early Stage
81
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
60 of 75 finished
20.0%
15 ended early
80
trials recruiting
175
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Psilocybin-Assisted Therapy
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Clinical Trials (175)
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Psilocybin-Assisted Therapy
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder
Psilocybin as a Novel Therapy for Residual Anhedonia
Psilocybin Administration With 5-HT1a Blockade
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Psilocybin in Chronic Low Back Pain and Depression
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Effects of Psilocybin in Obsessive Compulsive Disorder
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 175